Results Snapshot
Quarterly Analysis Highlights - QoQ
Net Sales
QoQ Growth in quarter ended Sep 2025 is 43.31% vs 107.30% in Jun 2025
Consolidate Net Profit
QoQ Growth in quarter ended Sep 2025 is 69.92% vs 163.10% in Jun 2025
Operating Profit (PBDIT) excl Other Income
QoQ Growth in quarter ended Sep 2025 is 71.87% vs 550.50% in Jun 2025
Interest
QoQ Growth in quarter ended Sep 2025 is 0.00% vs 3.70% in Jun 2025
Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Sep 2025 has improved from Jun 2025
Compare Quarterly Results Of Ironwood Pharmaceuticals, Inc. With
Quarterly - Net Sales
QoQ Growth in quarter ended Sep 2025 is 43.31% vs 107.30% in Jun 2025
YoY Growth in quarter ended Sep 2025 is 33.30% vs -19.44% in Sep 2024
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Sep 2025 is 69.92% vs 163.10% in Jun 2025
YoY Growth in quarter ended Sep 2025 is 1,013.89% vs -74.29% in Sep 2024
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Sep 2025 is 71.87% vs 550.50% in Jun 2025
YoY Growth in quarter ended Sep 2025 is 125.36% vs -29.33% in Sep 2024
Quarterly - Interest
QoQ Growth in quarter ended Sep 2025 is 0.00% vs 3.70% in Jun 2025
YoY Growth in quarter ended Sep 2025 is -10.64% vs -4.08% in Sep 2024
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Sep 2025 has improved from Jun 2025
YoY Growth in quarter ended Sep 2025 has improved from Sep 2024






